StockMacro
Company, fund or insider

Help

Menu

Andrew Combs

Insider (Form 4 reporting owner): Chief Chemistry Officer CIK 1825005Name as filed: Combs AndrewIts filings on EDGARAll insiders

Measures activity, not value. Not investment advice.

Since 29 Sep 2020, bought $269K in 4 open-market purchases of Prelude Therapeutics.

Companies

Role on the latest Form 4 for each; open-market trades counted
CompanyRoleTrades fromtoPurchasesSales
Prelude Therapeutics PRLDChief Chemistry Officer29 Sep 202025 Mar 20254$269K–

What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.

Median return minus the sector fund, in percentage points; "too few trades" under 5
Open-market tradesAfter 3 monthsAfter 6 monthsAfter 12 months
After purchasestoo few trades4 tradestoo few trades4 tradestoo few trades4 trades

For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.

By year

Counted open-market trades, by trade date
YearPurchasesBoughtSalesSoldNet
20251$69K––$69K
20241$86K––$86K
20211$95K––$95K
20201$19K––$19K

Every trade

4, newest first; open-market purchases and sales only
Trade dateCompanySideSharesPriceValuePlanned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. Filing
25 Mar 2025Prelude Therapeutics PRLDBuy100,000$0.69$69KNoForm 4filed 27 Mar 2025
20 Dec 2024Prelude Therapeutics PRLDBuy63,075$1.36$86KNoForm 4filed 26 Dec 2024
13 Dec 2021Prelude Therapeutics PRLDBuy8,000$11.86$95KNot statedForm 4filed 15 Dec 2021
29 Sep 2020Prelude Therapeutics PRLDBuy1,000$19.00$19KNot statedForm 4filed 29 Sep 2020

From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.